BECTON DICKINSON & CO (BDX)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$187.52
+0.21%
Investru Score
49.6 / 100
Neutral
Why is BDX moving?
BDX is little changed today (+0.21%).
Business overview
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bull case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
Bear case
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
BDX’s Investru Score changed +0.3 points recently. Want to know exactly what changed and why? That’s a Pro feature →
Score breakdown
- Financial Quality
- 55
- Growth
- 35
- Profitability
- 36
- Balance Sheet
- 32
- Valuation
- 66
- Momentum
- 88
Score history
+0.3 over the last 2 days, driven mainly by momentum (+3).
Financial quality
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- ROIC
- 3.9%
- ROE
- 6.6%
- FCF Margin
- 12.2%
- Free Cash Flow (TTM)
- $2.7B
- Earnings Quality (OCF ÷ Net Income)
- 2.0x
Valuation
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
- P/E (TTM)
- Data unavailable
- Forward P/E
- Data unavailable
- PEG (P/E ÷ EPS Growth)
- Data unavailable
- Company Median PEG
- Data unavailable
- Price / Sales
- 0.0x
- EV / EBITDA
- 3.8x
- FCF Yield
- Data unavailable
Key risks
- AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.(Probability: Medium · Impact: Medium)
Latest earnings
- Q3 FY26 EPS
- $1.37
- Estimate
- Data unavailable
- Surprise
- Data unavailable
AI explanation unavailable — the numeric report above is real; only this narrative text couldn't be generated right now.
SEC filings
- 10-Q · Q3 FY26 · period ended 2026-06-30Filed 2026-08-06
- 10-Q · Q2 FY26 · period ended 2026-03-31Filed 2026-05-07
- 10-Q · Q1 FY26 · period ended 2025-12-31Filed 2026-02-09
- 10-K · FY25 · period ended 2025-09-30Filed 2025-11-25
- 10-Q · Q3 FY25 · period ended 2025-06-30Filed 2025-08-07
- 10-K · FY24 · period ended 2024-09-30Filed 2024-11-27
- 10-K · FY23 · period ended 2023-09-30Filed 2023-11-21
- 10-K · FY22 · period ended 2022-09-30Filed 2022-11-22
- 10-K · FY21 · period ended 2021-09-30Filed 2021-11-24
Event filings (8-K) aren't covered by this page's data source yet — only 10-K/10-Q are shown above.
Market cap $0 · 52-week range $127.59–$193.07 · market data as of Sep 2, 2026, 4:00 PM ET · latest SEC filing: 2026-08-06
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze BDX with Investru AINot investment advice. Investru AI summarizes public data and AI-generated analysis for informational purposes only.